$IMMU stair steps 5 months Upper bollie $6.63 Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
844
$IMMU stair steps 5 months
Upper bollie $6.63
Nasdaq GM

Website
g493318logo.jpg

Last ten trades


10-Q 2/10/17
1642481658_otc.jpeg

80% x 100% Strong Buy
850318709_barchart_logo1.jpg

Shares Outstanding 106.08M
Float 89.45M

% Held by Insiders 6.84%
% Held by Institutions 43.70%
Shares Short 3 21.88M
Short Ratio 4.12
Short % of Float 21.98%
Shares Short (prior month) 23.57M


Stock technical analysis

895828223_stockta5.jpg

News
and filings

Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and epratuzumab, a humanized antibody that targets CD22, an antigen found on the surface of B lymphocytes. Its early-stage products include IMMU-114, a novel humanized antibody for the treatment of patients with B-cell and other cancers; Milatuzumab, a humanized monoclonal antibody targeting tumors that expresses the CD74 antigen, which is present on various hematological tumors and solid cancers; Veltuzumab, a humanized monoclonal antibody targeting CD20 receptors on B lymphocytes for the treatment of non-Hodgkin lymphoma and autoimmune diseases; and Yttrium-90-Labeled Epratuzumab Tetraxetan, a radiolabeled anti-CD22 investigational product. The company also provides LeukoScan, a diagnostic imaging product for diagnostic imaging to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a research collaboration with The Bayer Group to study epratuzumab as a thorium-227-labeled antibody. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.


bottomphoto22.png

Pipeline3.jpg

Immunomedics Inc. (IMMU) Stock Research Links

IMMU Board Company Profile Buy Rating Time & Sales News Filings Financials
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

OneAscent Welcomes Monica Stoudemire as New CCO

Updated Category News Views 3

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 3

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 1

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Helio Fred Garcia Honored by Diversity Action Alliance

Updated Category News Views 4

Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...

Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth

Updated Category News Views 4

Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...

Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action

Updated Category News Views 4

Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Diaper Affordability: A Hidden Crisis, Taxpayer Burden

Updated Category News Views 6

A Silent Crisis Lurking in Diapers Diapers. We don’t think about them much until we need them, but nearly half of U.S. families are painfully aware of their cost. According to a report from the NDBN Diaper Check 2026, many struggle to meet this basic necessity. This isn't just about keeping babies clean—it's a public health issue with economic ripples Congress can't...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading

Top 5 Most Recently Viewed Articles

Strategic Leadership Growth at Nowadays with New Director

Updated Category News Views 141

Strategic Leadership Growth at Nowadays with New Director Former TTB Regulatory Leader Tapped to Help Guide the Future of Hemp-Derived THC Beverages Amid Evolving Policy Landscape Nowadays, a fast-growing THC-infused beverage brand, has announced the appointment of Christopher Forster-Smith as its new Director of Regulatory Affairs. In this pivotal role, he will be...

Continue Reading
Exciting Culinary Experiences Await at 2025 Food Festival

Updated Category News Views 271

2025 Nassau Paradise Island Wine & Food Festival Announced The highly anticipated 2025 Nassau Paradise Island Wine & Food Festival is set to return, attracting food enthusiasts with its star-studded lineup of culinary talent. Celebrated chefs such as Bobby Flay, Kardea Brown, Katie Lee, and Michael Symon will headline this extraordinary event, bringing their exceptional...

Continue Reading
Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge

Updated Category News Views 151

Ryp Labs Triumphs in Lineage’s Global Food Innovation Challenge In a groundbreaking moment for sustainable food technology, Ryp Labs was announced as the standout winner of Lineage's prestigious innovation challenge aimed at transforming the global food supply chain. The challenge focused on innovative solutions that address pressing issues such as food waste and supply...

Continue Reading
Old Point Financial Achieves 52-Week Record Performance

Updated Category News Views 178

Old Point Financial Corporation Soars to New Heights Old Point Financial Corporation (OPOF) has recently made headlines as its stock surged to a remarkable 52-week high, now valued at $20.33. This achievement is not just a number; it symbolizes the growing confidence among investors regarding the company’s financial stability and future growth prospects. Over the past...

Continue Reading
Investigation of Starbucks: Are Investor Rights Being Breached?

Updated Category News Views 256

Starbucks Faces Investigation: What Long-Term Shareholders Need to Know Bragar Eagel & Squire, P.C., a well-known law firm, is currently investigating Starbucks Corporation (NASDAQ: SBUX) on behalf of long-term stockholders. This action follows a class action lawsuit, aimed at determining whether the company's board of directors has acted in the best interests of its...

Continue Reading